Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
SALT LAKE CITY, May 26, 2020 Elevar Therapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing promising therapies to address unmet needs in cancer, today announced that Mark Gelder, M.D. has been named vice president of medical affairs, effective immediately. Dr. Gelder will build and